ScreenCancer has recently been approved for the first round of the Horizon 2020 programme. Horizon 2020 is the biggest EU Research and Innovation programme ever. The idea behind the initiative is to ensure European economic growth and job creation by supporting companies with great ideas who utilise world-class science and innovation. SceenCancer, together with the rest of the DeepX Health group, are proud to be a successful applicant for the programme and are excited to be recognised for our work.
Pharmacy Screening Demonstrates Great Efficiency and Potential for Cost ReductionsRead more
Primary Care Setting Pilot Launched with NHSRead more
DeepX Health to Present at the 8th World Congress of Teledermatology, Imaging and Artificial Intelligence for Skin DiseasesRead more
ScreenCancer Awarded Support for Diagnostic Triage Algorithm-ProjectRead more
DeepX Health to participate at the 7th Annual Dermatology Summit in San FranciscoRead more
DeepX Health to present at Digital Health World Congress in LondonRead more
DeepX Health participate in the DxPx ConferenceRead more